Biology of hypoxia

Seminars in Nuclear Medicine

Volumn 45, Issue 2, 2015, Pages 101-109

  Span, Paul N ^a   Bussink, Johan ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; ADENOSINE PHOSPHATE; HYPOXIA INDUCIBLE FACTOR 1; MAMMALIAN TARGET OF RAPAMYCIN; MEMBRANE PROTEIN; MICRORNA; NITROIMIDAZOLE DERIVATIVE; OXYGEN; PIMONIDAZOLE; PROTEIN KINASE B; PROTEIN P53;

APOPTOSIS; ARTICLE; EPIGENETICS; GENE EXPRESSION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HYPOXIA; INTRACELLULAR SIGNALING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXYGEN CONSUMPTION; OXYGEN TENSION; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; UNFOLDED PROTEIN RESPONSE; ANIMAL; CELL HYPOXIA; GENETICS; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; VASCULARIZATION;

ANIMALS; CELL HYPOXIA; HUMANS; NEOPLASMS; TUMOR MICROENVIRONMENT;

EID: 84924058436     PISSN: 00012998     EISSN: 15584623     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2014.10.002     Document Type: Review

References (96)

1. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: The next generation Cell 144 2011 646 674
2. J. Bussink, J.H. Kaanders, and P.F. Rijken Changes in blood perfusion and hypoxia after irradiation of a human squamous cell carcinoma xenograft tumor line Radiat Res 153 2000 398 404
3. B. Burnette, and R.R. Weichselbaum Radiation as an immune modulator Semin Radiat Oncol 23 2013 273 280
4. R.K. Jain Normalizing tumor microenvironment to treat cancer: Bench to bedside to biomarkers J Clin Oncol 31 2013 2205 2218
5. J.S. Russell, and J.M. Brown The irradiated tumor microenvironment: Role of tumor-associated macrophages in vascular recovery Front Physiol 4 2013 157
6. T.W. Meijer, J.H. Kaanders, and P.N. Span Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy Clin Cancer Res 18 2012 5585 5594
7. A.J. van der Kogel, and M. Joiner Glossary terms in radiation biology Basic Clinical Radiobiology 4th ed (pp 356). 2009 Taylor & Francis Abingdon, Oxon
8. M. Höckel, and P. Vaupel Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects J Natl Cancer Inst 93 2001 266 276
9. S.E. Rademakers, P.N. Span, and J.H. Kaanders Molecular aspects of tumour hypoxia Mol Oncol 2 2008 41 53
10. G. Schwarz Ueber Desensibilisierung gegen Roentgen - Und Radiumstrahlen Muenchner Med Wochenschr 56 1909 1217 1218
11. A.G. Ide, N.H. Baker, and S.L. Warren Vascularization of the Brown Pearce rabbit epithelioma transplant as seen in the transparent ear chamber Am J Roentgenol 42 1939 891 899
12. G.H. Algire, H.W. Chalkley, and F.Y. Legallais Vascular reactions of normal and malignant tissues in vivo. I. Vascular reactions of mice to wounds and to normal and neoplastic transplants J Natl Cancer Inst 6 1945 73 85
13. J. Folkman Tumor angiogenesis: Therapeutic implications N Engl J Med 285 1971 1182 1186
14. E.M. Hendriksen, P.N. Span, and J. Schuuring Angiogenesis, hypoxia and VEGF expression during tumour growth in a human xenograft tumour model Microvasc Res 77 2009 96 103
15. M.A. Konerding, W. Malkusch, and B. Klapthor Evidence for characteristic vascular patterns in solid tumours: Quantitative studies using corrosion casts Br J Cancer 80 1999 724 732
16. H.J. Bernsen, P.F. Rijken, and T. Oostendorp Vascularity and perfusion of human gliomas xenografted in the athymic nude mouse Br J Cancer 71 1995 721 726
17. H. Stegeman, S.E. Rademakers, and P.N. Span Hypoxia, metabolism, and growth factor signaling in head and neck squamous cell carcinoma: Correlation between primary and xenograft tumors Head Neck 36 2014 1288 1295
18. T.W. Secomb, R. Hsu, and E.T. Ong Analysis of the effects of oxygen supply and demand on hypoxic fraction in tumors Acta Oncol 34 1995 313 316
19. R.H. Thomlinson, and L.H. Gray The histological structure of some human lung cancers and the possible implications for radiotherapy Br J Cancer 9 1955 539 549
20. 2 gradients in window chamber tumours: Impact on tumour hypoxia Br J Cancer 79 1999 1717 1722
21. J.M. Brown Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation Br J Radiol 52 1979 650 656
22. 2 fluctuation pattern and cycling hypoxia in human cervical carcinoma and melanoma xenografts Int J Radiat Oncol Biol Phys 83 2012 1317 1323
23. P. Vaupel, and A. Mayer Hypoxia in tumors: Pathogenesis-related classification, characterization of hypoxia subtypes, and associated biological and clinical implications Adv Exp Med Biol 812 2014 19 24
24. A.S. Ljungkvist, J. Bussink, and J.H. Kaanders Hypoxic cell turnover in different solid tumor lines Int J Radiat Oncol Biol Phys 62 2005 1157 1168
25. A.S. Ljungkvist, J. Bussink, and J.H. Kaanders Dynamics of tumor hypoxia measured with bioreductive hypoxic cell markers Radiat Res 167 2007 127 145
26. 2 tension measurements Cancer Res 51 1991 3316 3322
27. J. Bussink, J.H. Kaanders, and A.M. Strik Effects of nicotinamide and carbogen on oxygenation in human tumor xenografts measured with luminescense based fiber-optic probes Radiother Oncol 57 2000 21 30
28. M. Nordsmark, M. Overgaard, and J. Overgaard Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck Radiother Oncol 41 1996 31 39
29. S.S. Foo, D.F. Abbott, and N. Lawrentschuk Functional imaging of intratumoral hypoxia Mol Imaging Biol 6 2004 291 305
30. B. Gallez, C. Baudelet, and B.F. Jordan Assessment of tumor oxygenation by electron paramagnetic resonance: Principles and applications NMR Biomed 17 2004 240 262
31. F. Goda, J.A. OHara, and E.S. Rhodes Changes of oxygen tension in experimental tumors after a single dose of X-ray irradiation Cancer Res 55 1995 2249 2252
32. 19F magnetic resonance spectroscopy Int J Radiat Biol 58 1990 1025 1034
33. 19F magnetic resonance spectroscopy and immunohistochemistry Radiat Res 129 1992 71 78
34. R.P. Mason, P.P. Antich, and E.E. Babcock Non-invasive determination of tumor oxygen tension and local variation with growth Int J Radiat Oncol Biol Phys 29 1994 95 103
35. S.P. Robinson, F.A. Howe, and M. Stubbs Effects of nicotinamide and carbogen on tumour oxygenation, blood flow, energetics and blood glucose levels Br J Cancer 82 2000 2007 2014
36. S.M. Evans, K.L. Du, and A.A. Chalian Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome Int J Radiat Oncol Biol Phys 69 2007 1024 1031
37. G.O. Janssens, S.E. Rademakers, and C.H. Terhaard Accelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: Results of a phase III randomized trial J Clin Oncol 30 2012 1777 1783
38. G.E. Arteel, R.G. Thurman, and J.M. Yates Evidence that hypoxia markers detect oxygen gradients in liver: Pimonidazole and retrograde perfusion of rat liver Br J Cancer 72 1995 889 895
39. M.W. Gross, U. Karbach, and K. Groebe Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids Int J Cancer 61 1995 567 573
40. A.I. Minchinton, R.E. Durand, and D.J. Chaplin Intermittent blood flow in the KHT sarcoma - Flow cytometry studies using Hoechst 33342 Br J Cancer 62 1990 195 200
41. J. Bussink, J.H. Kaanders, and P.F. Rijken Vascular architecture and microenvironmental parameters in human squamous cell carcinoma xenografts: Effects of carbogen and nicotinamide Radiother Oncol 50 1999 173 184
42. 18F]FMISO autoradiography and pimonidazole immunohistochemistry in human head and neck carcinoma xenografts Eur J Nucl Med Mol Imaging 35 2008 1803 1811
43. 18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors Radiother Oncol 80 2006 157 164
44. 18F-FDG PET early response evaluation of locally advanced non-small cell lung cancer treated with concomitant chemoradiotherapy J Nucl Med 54 2013 1528 1534
45. J. Bussink, C.M. van Herpen, and J.H. Kaanders PET-CT for response assessment and treatment adaptation in head and neck cancer Lancet Oncol 11 2010 661 669
46. G.L. Semenza Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics Oncogene 29 2010 625 634
47. G.L. Semenza Regulation of cancer cell metabolism by hypoxia-inducible factor 1 Semin Cancer Biol 19 2009 12 16
48. R.J. Gillies, I. Robey, and R.A. Gatenby Causes and consequences of increased glucose metabolism of cancers J Nucl Med 49 2008 24S 42S
49. H.L. Sun, Y.N. Liu, and Y.T. Huang YC-1 inhibits HIF-1 expression in prostate cancer cells: Contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia Oncogene 26 2007 3941 3951
50. M.W. Dewhirst, Y. Cao, and B. Moeller Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response Nat Rev Cancer 8 2008 425 437
51. P. Manders, F.C. Sweep, and V.C. Tjan-Heijnen Vascular endothelial growth factor independently predicts the efficacy of postoperative radiotherapy in node-negative breast cancer patients Clin Cancer Res 9 2003 6363 6370
52. P.N. Span, J. Bussink, and P. Manders Carbonic anhydrase-9 expression levels and prognosis in human breast cancer: Association with treatment outcome Br J Cancer 89 2003 271 276
53. B.G. Wouters, and M. Koritzinsky Hypoxia signalling through mTOR and the unfolded protein response in cancer Nat Rev Cancer 8 2008 851 864
54. D.E. Feldman, V. Chauhan, and A.C. Koong The unfolded protein response: A novel component of the hypoxic stress response in tumors Mol Cancer Res 3 2005 597 605
55. C. Koumenis, and B.G. Wouters "Translating" tumor hypoxia: Unfolded protein response (UPR)-dependent and UPR-independent pathways Mol Cancer Res 4 2006 423 436
56. C. Koumenis, C. Naczki, and M. Koritzinsky Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha Mol Cell Biol 22 2002 7405 7416
57. J.D. Blais, V. Filipenko, and M. Bi Activating transcription factor 4 is translationally regulated by hypoxic stress Mol Cell Biol 24 2004 7469 7482
58. K. Ameri, C.E. Lewis, and M. Raida Anoxic induction of ATF-4 through HIF-1-independent pathways of protein stabilization in human cancer cells Blood 103 2004 1876 1882
59. T. Rzymski, M. Milani, and D.C. Singleton Role of ATF4 in regulation of autophagy and resistance to drugs and hypoxia Cell Cycle 8 2009 3838 3847
60. A. Nagelkerke, J. Bussink, and H. Mujcic Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein response Breast Cancer Res 15 2013 R2
61. H. Mujcic, A. Nagelkerke, and K.M. Rouschop Hypoxic activation of the PERK/eIF2α arm of the unfolded protein response promotes metastasis through induction of LAMP3 Clin Cancer Res 19 2013 6126 6137
62. A. Nagelkerke, J. Bussink, and A.J. van der Kogel The PERK/ATF4/LAMP3-arm of the unfolded protein response affects radioresistance by interfering with the DNA damage response Radiother Oncol 108 2013 415 421
63. A. Nagelkerke, A.M. Sieuwerts, and J. Bussink LAMP3 is involved in tamoxifen resistance in breast cancer cells through the modulation of autophagy Endocr Relat Cancer 21 2014 101 112
64. A. Nagelkerke, F.C. Sweep, and A. Geurts-Moespot Therapeutic targeting of autophagy in cancer. Part I: Molecular pathways controlling autophagy Semin Cancer Biol 2014 10.1016/j.semcancer.2014.05.004
65. A. Nagelkerke, J. Bussink, and F.C. Sweep The unfolded protein response as a target for cancer therapy Biochim Biophys Acta 1846 2014 277 284
66. A. Nagelkerke, J. Bussink, and A. Geurts-Moespot Therapeutic targeting of autophagy in cancer. Part II: Pharmacological modulation of treatment-induced autophagy Semin Cancer Biol 2014 10.1016/j.semcancer.2014.06.001
67. K.M. Rouschop, T. van den Beucken, and L. Dubois The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5 J Clin Invest 120 2010 127 141
68. H. Stegeman, J.H. Kaanders, and D.L. Wheeler Activation of AKT by hypoxia: A potential target for hypoxic tumors of the head and neck BMC Cancer 12 2012 463
69. E. Laughner, P. Taghavi, and K. Chiles HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression Mol Cell Biol 21 2001 3995 4004
70. C.C. Hudson, M. Liu, and G.G. Chiang Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin Mol Cell Biol 22 2002 7004 7014
71. G. Ruvkun Molecular biology. Glimpses of a tiny RNA world Science 294 2001 797 799
72. A. Esquela-Kerscher, and F.J. Slack Oncomirs - MicroRNAs with a role in cancer Nat Rev Cancer 6 2006 259 269
73. A.K. Leung, and P.A. Sharp MicroRNA functions in stress responses Mol Cell 40 2010 205 215
74. P. Soon, and H. Kiaris MicroRNAs in the tumour microenvironment: Big role for small players Endocr Relat Cancer 20 2013 R257 R267
75. R. Kulshreshtha, M. Ferracin, and S.E. Wojcik A microRNA signature of hypoxia Mol Cell Biol 27 2007 1859 1867
76. C. Camps, F.M. Buffa, and S. Colella hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer Clin Cancer Res 14 2008 1340 1348
77. P. Fasanaro, Y. DAlessandra, and V. Di Stefano MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3 J Biol Chem 283 2008 15878 15883
78. Q. Qin, W. Furong, and L. Baosheng Multiple functions of hypoxia-regulated miR-210 in cancer J Exp Clin Cancer Res 33 2014 50
79. Y.P. Tsai, and K.J. Wu Epigenetic regulation of hypoxia-responsive gene expression: Focusing on chromatin and DNA modifications Int J Cancer 134 2014 249 256
80. A.B. Johnson, and M.C. Barton Hypoxia-induced and stress-specific changes in chromatin structure and function Mutat Res 618 2007 149 162
81. A.B. Johnson, N. Denko, and M.C. Barton Hypoxia induces a novel signature of chromatin modifications and global repression of transcription Mutat Res 640 2008 174 179
82. C.A. Brady, and L.D. Attardi p53 at a glance J Cell Sci 123 2010 2527 2532
83. E.M. Hammond, N.C. Denko, and M.J. Dorie Hypoxia links ATR and p53 through replication arrest Mol Cell Biol 22 2002 1834 1843
84. E.M. Hammond, M.J. Dorie, and A.J. Giaccia ATR/ATM targets are phosphorylated by ATR in response to hypoxia and ATM in response to reoxygenation J Biol Chem 278 14 2003 12207 12213
85. R. Alarcón, C. Koumenis, and R.K. Geyer Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation Cancer Res 59 1999 6046 6051
86. J.H. Lee, Y. Jin, and G. He Hypoxia activates tumor suppressor p53 by inducing ATR-Chk1 kinase cascade-mediated phosphorylation and consequent 14-3-3γ inactivation of MDMX protein J Biol Chem 287 2012 20898 20903
87. E.M. Hammond, and A.J. Giaccia The role of p53 in hypoxia-induced apoptosis Biochem Biophys Res Commun 331 2005 718 725
88. E.M. Hammond, D.J. Mandell, and A. Salim Genome-wide analysis of p53 under hypoxic conditions Mol Cell Biol 26 2006 3492 3504
89. T.M. Johnson, E.M. Hammond, and A. Giaccia The p53QS transactivation-deficient mutant shows stress-specific apoptotic activity and induces embryonic lethality Nat Genet 37 2005 145 152
90. T.G. Graeber, C. Osmanian, and T. Jacks Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours Nature 379 1996 88 91
91. R.J. Gillies, and R.A. Gatenby Adaptive landscapes and emergent phenotypes: Why do cancers have high glycolysis? J Bioenerg Biomembr 39 2007 251 257
92. V. Ganapathy, M. Thangaraju, and P.D. Prasad Nutrient transporters in cancer: Relevance to Warburg hypothesis and beyond Pharmacol Ther 121 2009 29 40
93. M.C. Brahimi-Horn, J. Chiche, and J. Pouysségur Hypoxia signalling controls metabolic demand Curr Opin Cell Biol 19 2007 223 229
94. M. Busk, M.R. Horsman, and S. Jakobsen Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage Eur J Nucl Med Mol Imaging 35 2008 2294 2303
95. H. Lu, R.A. Forbes, and A. Verma Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis J Biol Chem 277 2002 23111 23115
96. T. McFate, A. Mohyeldin, and H. Lu Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells J Biol Chem 283 2008 22700 22708